# Non-invasive Melanoma Assessment Using a Topical Fluorescence Reagent and Optical Imaging

> **NCT02056522** · — · COMPLETED · sponsor: **Orlucent, Inc** · enrollment: 357 (actual)

## Conditions studied

- Skin Lesions

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02056522
- **Lead sponsor:** Orlucent, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07
- **Primary completion:** 2018-04
- **Final completion:** 2018-07
- **Target enrollment:** 357 (ACTUAL)
- **Last updated:** 2020-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02056522

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02056522, "Non-invasive Melanoma Assessment Using a Topical Fluorescence Reagent and Optical Imaging". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02056522. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*